Research Article
Cost-Effectiveness Analysis of Fosfomycin for Treatment of Uncomplicated Urinary Tract Infections in Ontario
Table 1
Cost of antibiotics and healthcare resources used for the treatment of uUTIs and the ranges tested in the sensitivity analyses.
| Variable | Base case (CAD $) | Range tested (CAD $) | References |
| Fosfomycin | 17.51 | 13.00–18.00 | [23], Pharmastat | Sulfonamides | 0.95 | 0.88–2.79 | [23], Pharmastat | Fluoroquinolones | 4.25 | 3.71–11.78 | [23], Pharmastat | Nitrofurantoin | 10.54 | 4.68–11.12 | [23], Pharmastat | Hospitalization for pyelonephritis | 6,918.15 | 4,842.71–8,993.60 | OCCI, hypothesis of plausible range (±30% of base case) | Initial clinic visit | 77.20 | — | [24] | Follow-up clinic visit | 45.90 | — | [24] | Urine culture | 45.00 | — | Laboratoires Biron, oral communication, May 30 2016 | Emergency visit | 287.6 | — | [24–26] |
|
|
mergency MD cost ($97.60) + total cost for an emergency visit in Quebec in 2009, MD cost excluded ($190).
|